tiprankstipranks
Arbutus Biopharma Corporation (ABUS)
NASDAQ:ABUS
Holding ABUS?
Track your performance easily

Arbutus Biopharma (ABUS) Ownership - Who Owns Arbutus Biopharma?

1,217 Followers

Arbutus Biopharma (ABUS) Ownership Overview

1.90%9.78%20.14%9.67%58.51%
20.14% Other Institutional Investors
9.67% ETFs
58.51% Public Companies and
Individual Investors
The ownership structure of Arbutus Biopharma (ABUS) stock is a mix of institutional, retail, and individual investors. Approximately 39.58% of the company’s stock is owned by Institutional Investors, 1.90% is owned by Insiders, and 58.51% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 16, 2024
xxxxxxxxxxxxx
$32553

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$2572389
Sep 30, 2024
xxxxxxxxxxxxx
$2604243

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
8,318,040Institution4.39%28,447,697
7,112,353Institution3.75%24,324,247
5,851,107Institution3.09%20,010,786
4,237,726Institution2.24%14,493,023
3,007,024Institution1.59%10,284,022
1,652,283Insider0.87%5,650,808
1,584,066Institution0.84%5,417,506
1,571,467Institution0.83%5,374,417
1,504,793Insider0.79%5,146,392
1,494,288Institution0.79%5,110,465

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
5,851,107Institution3.09%20,010,786
4,237,726Institution2.24%14,493,023
3,007,024Institution1.59%10,284,022
1,584,066Institution0.84%5,417,506
1,571,467Institution0.83%5,374,417
708,562Institution0.37%2,423,282
484,841Institution0.26%1,658,156
389,070Institution0.21%1,330,619
119,304Institution0.06%408,020
107,845Institution0.06%368,830

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
4,924,732Institution2.60%18,935,595
3,991,726Institution2.11%13,651,703
2,351,187Institution1.24%9,040,314
1,224,278Institution0.65%4,297,216
1,224,303Institution0.65%4,187,116
1,016,782Institution0.54%3,477,394
665,231Institution0.35%2,557,813
712,952Institution0.38%2,502,462
336,695Institution0.18%1,151,497
228,197Institution0.12%780,434

FAQ

Who Owns Arbutus Biopharma Corporation (ABUS)?
According to the latest TipRanks data, approximately 20.14% of the company's stock is held by institutional investors, 1.90% is held by insiders, and 58.51% is held by retail investors.
    What percentage of Arbutus Biopharma Corporation (ABUS) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 20.14% of Arbutus Biopharma Corporation (ABUS) stock is held by institutional investors.
      What percentage of Arbutus Biopharma Corporation (ABUS) stock is held by retail investors?
      According to the latest TipRanks data, approximately 58.51% of Arbutus Biopharma Corporation (ABUS) stock is held by retail investors.
        Who owns the most shares of Arbutus Biopharma Corporation (ABUS)?
        Vanguard owns the most shares of Arbutus Biopharma Corporation (ABUS).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis